Press "Enter" to skip to content

FDA, Canada, Australia Collaborate On Cancer Drugs Review

FDA, Canada, Australia Collaborate On Cancer Drugs Review

The U.S. Food and Drug Administration on Tuesday unveiled a new international collaboration for simultaneous review and approval of cancer drugs along with the agency’s Australian and Canadian counterparts. The simultaneous approval of cancer therapies by the three regulators is intended to accelerate the process of making these new treatments available to patients around the world.
Source: FDA, Canada, Australia Collaborate On Cancer Drugs Review

Facebook Comments

Disqus Comments

Specify a Disqus shortname at Social Comments options page in admin panel